All market verdicts

TEM UP market verdict | Ezbrisk

Published: 1786124525487

Anomaly score: 2.7610965614540337

Confidence: 0.75

Market summary

Tempus AI surges violently

Ezbrisk assessment

TEM is rallying violently on news that CellCarta added Tempus to its CDx commercialization lab network, a partnership that expands Tempus's reach in precision diagnostics and companion diagnostic development.

Sources: https://www.clinicalresearchnewsonline.com/news/2026/08/07/cellcarta-adds-tempus-to-cdx-commercialization-lab-network, https://uk.finance.yahoo.com/quote/TEM/, https://seekingalpha.com/symbol/TEM, https://robinhood.com/us/en/stocks/TEM/, https://cellcarta.com/science-hub/cellcarta-tempus-ai-strategic-partnership/

Verdict ID: abb3a036-33bd-4eb8-95c5-40e5ee0f273a